IL4 and acute lymphoblastic leukemia: Stachel et al. showed the increased expression of IL-4 mRNA in the bone marrow of 49 pediatric patients with B cell precursor ALL with late relapse proposing that ALL leukemic cells mediate a shift toward Th2 responses and, thus, influence the relapse risk [20].